Genomic analysis of ERVWE2 locus in patients with multiple sclerosis: absence of genetic association but potential role of human endogenous retrovirus type W elements in molecular mimicry with myelin antigen

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorOLIVAL, Guilherme S. do
dc.contributor.authorFARIA, Thiago S.
dc.contributor.authorNALI, Luiz H. S.
dc.contributor.authorOLIVEIRA, Augusto C. P. de
dc.contributor.authorCASSEB, Jorge
dc.contributor.authorVIDAL, Jose E.
dc.contributor.authorCAVENAGHI, Vitor B.
dc.contributor.authorTILBERY, Charles P.
dc.contributor.authorMORAES, Lenira
dc.contributor.authorFINK, Maria C. S.
dc.contributor.authorSUMITA, Laura M.
dc.contributor.authorPERRON, Herve
dc.contributor.authorROMANO, Camila M.
dc.date.accessioned2014-04-25T22:03:01Z
dc.date.available2014-04-25T22:03:01Z
dc.date.issued2013
dc.description.abstractHuman endogenous retroviruses (HERVs) arise from ancient infections of the host germline cells by exogenous retroviruses, constituting 8% of the human genome. Elevated level of envelope transcripts from HERVs-W has been detected in CSF, plasma and brain tissues from patients with Multiple Sclerosis (MS), most of them from Xq22.3, 15q21.3, and 6q21 chromosomes. However, since the locus Xq22.3 (ERVWE2) lack the 5' LTR promoter and the putative protein should be truncated due to a stop codon, we investigated the ERVWE2 genomic loci from 84 individuals, including MS patients with active HERV-W expression detected in PBMC. In addition, an automated search for promoter sequences in 20 kb nearby region of ERVWE2 reference sequence was performed. Several putative binding sites for cellular cofactors and enhancers were found, suggesting that transcription may occur via alternative promoters. However, ERVWE2 DNA sequencing of MS and healthy individuals revealed that all of them harbor a stop codon at site 39, undermining the expression of a full-length protein. Finally, since plaque formation in central nervous system (CNS) of MS patients is attributed to immunological mechanisms triggered by autoimmune attack against myelin, we also investigated the level of similarity between envelope protein and myelin oligodendrocyte glycoprotein (MOG). Comparison of the MOG to the envelope identified five retroviral regions similar to the Ig-like domain of MOG. Interestingly, one of them includes T and B cell epitopes, capable to induce T effector functions and circulating Abs in rats. In sum, although no DNA substitutions that would link ERVWE2 to the MS pathogeny was found, the similarity between the envelope protein to MOG extends the idea that ERVEW2 may be involved on the immunopathogenesis of MS, maybe facilitating the MOG recognizing by the immune system. Although awaiting experimental evidences, the data presented here may expand the scope of the endogenous retroviruses involvement on MS pathogenesis.
dc.description.indexPubMed
dc.description.sponsorshipFAPESP [2010/10619-0]
dc.identifier.citationFRONTIERS IN MICROBIOLOGY, v.4, article ID 172, 7p, 2013
dc.identifier.doi10.3389/fmicb.2013.00172
dc.identifier.issn1664-302X
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/5235
dc.language.isoeng
dc.publisherFRONTIERS RESEARCH FOUNDATION
dc.relation.ispartofFrontiers in Microbiology
dc.rightsopenAccess
dc.rights.holderCopyright FRONTIERS RESEARCH FOUNDATION
dc.subjectmultiple sclerosis
dc.subjectimmunopathogeny
dc.subjectendogenous retroviruses
dc.subjectERVWE2
dc.subjectgenetic association
dc.subjectMOG
dc.subject.otherplacental expression
dc.subject.otherherv-w
dc.subject.otherdisease
dc.subject.otherfamily
dc.subject.otherenv
dc.subject.otherretroelements
dc.subject.otherparticles
dc.subject.othersequences
dc.subject.otherpromoter
dc.subject.otherblood
dc.subject.wosMicrobiology
dc.titleGenomic analysis of ERVWE2 locus in patients with multiple sclerosis: absence of genetic association but potential role of human endogenous retrovirus type W elements in molecular mimicry with myelin antigen
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.affiliation.countrySuíça
hcfmusp.affiliation.countryisoch
hcfmusp.author.externalOLIVAL, Guilherme S. do:Irmandade Santa Casa Misericordia Sao Paulo, Dept Neurol, Sao Paulo, Brazil
hcfmusp.author.externalFARIA, Thiago S.:Univ Sao Paulo, Inst Med Trop Sao Paulo, Dept Molestias Infecc & Parasitarias LIMHC, BR-05403000 Sao Paulo, Brazil; Univ Sao Paulo, Fac Med, BR-05403000 Sao Paulo, Brazil
hcfmusp.author.externalOLIVEIRA, Augusto C. P. de:Inst Infectol Emilio Ribas, Dept Neurol, Sao Paulo, Brazil
hcfmusp.author.externalVIDAL, Jose E.:Inst Infectol Emilio Ribas, Dept Neurol, Sao Paulo, Brazil
hcfmusp.author.externalCAVENAGHI, Vitor B.:Irmandade Santa Casa Misericordia Sao Paulo, Dept Neurol, Sao Paulo, Brazil
hcfmusp.author.externalTILBERY, Charles P.:Irmandade Santa Casa Misericordia Sao Paulo, Dept Neurol, Sao Paulo, Brazil
hcfmusp.author.externalMORAES, Lenira:Univ Sao Paulo, Fac Med, Hosp Clin, Dept Neurol, BR-05403000 Sao Paulo, Brazil
hcfmusp.author.externalPERRON, Herve:Univ Sao Paulo, Fac Med, BR-05403000 Sao Paulo, Brazil; Geneuro, Geneva, Switzerland
hcfmusp.citation.scopus26
hcfmusp.contributor.author-fmusphcLUIZ HENRIQUE DA SILVA NALI
hcfmusp.contributor.author-fmusphcJORGE SIMAO DO ROSARIO CASSEB
hcfmusp.contributor.author-fmusphcMARIA CRISTINA DOMINGUES DA SILVA FINK
hcfmusp.contributor.author-fmusphcLAURA MASAMI SUMITA
hcfmusp.contributor.author-fmusphcCAMILA MALTA ROMANO
hcfmusp.description.articlenumber172
hcfmusp.description.volume4
hcfmusp.origemWOS
hcfmusp.origem.pubmed23805135
hcfmusp.origem.scopus2-s2.0-84884220242
hcfmusp.origem.wosWOS:000331180800001
hcfmusp.publisher.cityLAUSANNE
hcfmusp.publisher.countrySWITZERLAND
hcfmusp.relation.referenceAntony JM, 2004, NAT NEUROSCI, V7, P1088, DOI 10.1038/nn1319
hcfmusp.relation.referenceAntony JM, 2011, BBA-MOL BASIS DIS, V1812, P162, DOI 10.1016/j.bbadis.2010.07.016
hcfmusp.relation.referenceBannert N, 2004, P NATL ACAD SCI USA, V101, P14572, DOI 10.1073/pnas.0404838101
hcfmusp.relation.referenceBernard C C, 1991, Acta Neurol (Napoli), V13, P171
hcfmusp.relation.referenceBlond JL, 1999, J VIROL, V73, P1175
hcfmusp.relation.referenceChristensen T, 2003, MULT SCLER, V9, P6, DOI 10.1191/1352458503ms867oa
hcfmusp.relation.referenceClausen J, 2003, Int MS J, V10, P22
hcfmusp.relation.referenceColmegna I, 2006, INFECT DIS CLIN N AM, V20, P913, DOI 10.1016/j.idc.2006.09.008
hcfmusp.relation.referenceCostas J, 2002, MOL BIOL EVOL, V19, P526
hcfmusp.relation.referenceDolei A, 2009, J NEUROVIROL, V15, P4, DOI 10.1080/13550280802448451
hcfmusp.relation.referenceEhlhardt S, 2006, J RHEUMATOL, V33, P16
hcfmusp.relation.referenceFrith MC, 2001, BIOINFORMATICS, V17, P878, DOI 10.1093/bioinformatics/17.10.878
hcfmusp.relation.referenceGarson JA, 1998, LANCET, V351, P33, DOI 10.1016/S0140-6736(98)24001-3
hcfmusp.relation.referenceGregersen JW, 2006, NATURE, V443, P574, DOI 10.1038/nature05133
hcfmusp.relation.referenceIchikawa M, 1996, J IMMUNOL, V157, P919
hcfmusp.relation.referenceJones S., 1994, CAMBRIDGE ENCY HUMAN
hcfmusp.relation.referenceKomurian-Pradel F, 1999, VIROLOGY, V260, P1, DOI 10.1006/viro.1999.9792
hcfmusp.relation.referenceLander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
hcfmusp.relation.referenceLaufer G, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-37
hcfmusp.relation.referenceLee WJ, 2003, J GEN VIROL, V84, P2229, DOI 10.1099/vir.0.19076-0
hcfmusp.relation.referenceMacfarlane C, 2004, J MOL EVOL, V59, P642, DOI 10.1007/s00239-004-2656-1
hcfmusp.relation.referenceMameli G, 2009, J VIROL METHODS, V161, P98, DOI 10.1016/j.jviromet.2009.05.024
hcfmusp.relation.referenceMameli G, 2007, J GEN VIROL, V88, P264, DOI 10.1099/vir.0.81890-0
hcfmusp.relation.referenceMiller S., 2001, ADV VIRUS RES
hcfmusp.relation.referenceNellaker C, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-44
hcfmusp.relation.referenceOgasawara H, 2010, LUPUS, V19, P111, DOI 10.1177/0961203309106767
hcfmusp.relation.referenceOwens GP, 2011, NEUROSCIENTIST, V17, P659, DOI 10.1177/1073858411386615
hcfmusp.relation.referencePerron H, 2012, MULT SCLER J, V18, P1721, DOI 10.1177/1352458512441381
hcfmusp.relation.referencePerron H, 2001, VIROLOGY, V287, P321, DOI 10.1006/viro.2001.1045
hcfmusp.relation.referencePerron H, 2010, CLIN REV ALLERG IMMU, V39, P51, DOI 10.1007/s12016-009-8170-x
hcfmusp.relation.referencePerron H, 1997, P NATL ACAD SCI USA, V94, P7583, DOI 10.1073/pnas.94.14.7583
hcfmusp.relation.referencePolman Chris H., 2011, ANN NEUROL, V69, P292, DOI 10.1002/ANA.22366
hcfmusp.relation.referencePrudhomme S, 2004, J VIROL, V78, P12157, DOI 10.1128/JVI.78.22.12157-12168.2004
hcfmusp.relation.referenceRoebke C, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-69
hcfmusp.relation.referenceRolland A, 2006, J IMMUNOL, V176, P7636
hcfmusp.relation.referenceSchon U, 2001, VIROLOGY, V279, P280, DOI 10.1006/viro.2000.0712
hcfmusp.relation.referenceSchulz WA, 2006, CURR TOP MICROBIOL, V310, P211
hcfmusp.relation.referenceTai AK, 2008, MULT SCLER J, V14, P1175, DOI 10.1177/1352458508094641
hcfmusp.relation.referenceTrejbalova K, 2011, NUCLEIC ACIDS RES, V39, P8728, DOI 10.1093/nar/gkr562
hcfmusp.relation.referenceUrnovitz HB, 1996, CLIN MICROBIOL REV, V9, P72
hcfmusp.remissive.sponsorshipFAPESP
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublication6743664d-b48d-40e7-95cc-bbf2c329b353
relation.isAuthorOfPublicationdb8fd0fe-568d-426b-b59b-955d4d21c0a9
relation.isAuthorOfPublication24bd5f62-66d0-4549-99ca-23654a3a7649
relation.isAuthorOfPublicationd534f5aa-08bb-4ae7-8386-d40654c2c256
relation.isAuthorOfPublication6bbf3a61-ee5f-431c-b68d-7f040abc8f15
relation.isAuthorOfPublication.latestForDiscovery6743664d-b48d-40e7-95cc-bbf2c329b353
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
art_NALI_Genomic_analysis_of_ERVWE2_locus_in_patients_with_2013.PDF
Tamanho:
1.92 MB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)